Johnson and Johnson vaccine receives approval for emergency use.
The U.S. Food and Drug Administration issued emergency use authorization in the past few days for a third COVID-19 vaccine produced by Janssen Biotech. The approval of this single-dose vaccine is for distribution in the U.S. for use in individuals 18 years or older.
“After a thorough analysis of the data, the FDA’s scientists and physicians have determined that the vaccine meets the FDA’s expectations for safety and effectiveness appropriate for the authorization of a vaccine for emergency use,” said Director of the FDA’s Center for Biologics Evaluation and Research Dr. Peter Marks. “With today’s authorization, we are adding another vaccine in our medical toolbox to fight this virus. At the same time, the American people can be assured of the FDA’s unwavering commitment to public health through our comprehensive and rigorous evaluation of the data submitted for vaccines to prevent COVID-19.”
As the Lord Leads, Pray with Us…
- For the Department of Health and Human Services as they seek to prevent illness in the American population.
- For the Food and Drug Administration as therapeutics and vaccines continue to be screened for the prevention of the coronavirus.
- For God to work through the president’s administration to accomplish His purpose in the U.S.
Sources: FDA.gov
